The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2024
Filed:
Sep. 21, 2021
Applicant:
Infirst Healthcare Limited, London, GB;
Inventors:
Robin M. Bannister, Saffron Walden, GB;
John Brew, St. Albans, GB;
Richard R. Reiley, III, London, GB;
Wilson Caparros Wanderley, Aylesbury, GB;
Assignee:
Infirst Healthcare Limited, London, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); A61K 9/14 (2006.01); A61K 31/12 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/216 (2006.01); A61K 31/25 (2006.01); A61K 31/337 (2006.01); A61K 31/357 (2006.01); A61K 31/366 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/522 (2006.01); A61K 31/60 (2006.01); A61K 31/616 (2006.01); A61K 31/704 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 31/19 (2006.01); A61K 31/201 (2006.01);
U.S. Cl.
CPC ...
A61K 9/08 (2013.01); A61K 9/148 (2013.01); A61K 31/12 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/216 (2013.01); A61K 31/357 (2013.01); A61K 31/366 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/522 (2013.01); A61K 31/60 (2013.01); A61K 31/616 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 31/19 (2013.01); A61K 31/201 (2013.01); A61K 31/25 (2013.01); A61K 31/337 (2013.01); A61K 31/704 (2013.01);
Abstract
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.